Back
Avalo Therapeutics Stock Price Chart
Sponsored
AVTX
Sponsored
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
16
AVTX
Avalo Therapeutics
Last Price:
10.82
Seasonality Move:
-8.46%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight selling pressure.
Avalo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.35 | Sell |
20-day SMA: | 13.98 | Sell |
50-day SMA: | 11.01 | Sell |
200-day SMA: | 18.42 | Sell |
8-day EMA: | 12.82 | Sell |
20-day EMA: | 13.41 | Sell |
50-day EMA: | 12.07 | Sell |
200-day EMA: | 129.84 | Sell |
Avalo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 40.49 | Sell |
Chaikin Money Flow: | -11099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.43 - 15.89) | Sell |
Bollinger Bands (100): | (3.95 - 13.43) | Buy |
Avalo Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
- Avalo Therapeutics share price is 10.85 while AVTX 8-day simple moving average is 13.35, which is a Sell signal.
- The stock price of AVTX is 10.85 while Avalo Therapeutics 20-day SMA is 13.98, which makes it a Sell.
- Avalo Therapeutics 50-day simple moving average is 11.01 while AVTX share price is 10.85, making it a Sell technically.
- AVTX stock price is 10.85 and Avalo Therapeutics 200-day simple moving average is 18.42, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
16
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a Sell
The current Avalo Therapeutics [AVTX] share price is $10.85. The Score for AVTX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
11.22M
Price in USD:
10.85
Share Volume:
57.35K
Avalo Therapeutics 52-Week Range
52-Week High:
1,130.40
52-Week Low:
3.95
Sell
16
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?
The Avalo Therapeutics stock price is 10.85 USD today. -
Will AVTX stock go up or go down?
Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avalo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
- Avalo Therapeutics share price is 10.85 while AVTX 8-day exponential moving average is 12.82, which is a Sell signal.
- The stock price of AVTX is 10.85 while Avalo Therapeutics 20-day EMA is 13.41, which makes it a Sell.
- Avalo Therapeutics 50-day exponential moving average is 12.07 while AVTX share price is 10.85, making it a Sell technically.
- AVTX stock price is 10.85 and Avalo Therapeutics 200-day simple moving average is 129.84, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
- AVTX Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Avalo Therapeutics is a Buy
- Avalo Therapeutics Relative Strength Index (RSI) is 40.49, which suggest Avalo Therapeutics is oversold
- The Bollinger Bands (25) for Avalo Therapeutics is (12.43 - 15.89), which suggest Avalo Therapeutics is a Buy
- The Bollinger Bands (100) for Avalo Therapeutics is (3.95 - 13.43), which suggest Avalo Therapeutics is a Buy
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.